Larimar Therapeutics Ownership | Who Owns Larimar Therapeutics?


OverviewForecastRevenueFinancialsChart

Larimar Therapeutics Ownership Summary


Larimar Therapeutics is owned by 48.74% institutional investors, 1.43% insiders, and 49.83% retail investors. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 33.19% of LRMR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.10% of its assets in Larimar Therapeutics shares.

LRMR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLarimar Therapeutics48.74%1.43%49.83%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deerfield management company, l.p. (series c)21.23M33.19%$45.65M
Janus henderson group6.44M10.10%$24.94M
Ra capital management6.05M9.45%$13.00M
Blue owl capital lp4.65M7.29%$18.01M
Goldman sachs group4.15M6.51%$16.07M
Blackrock3.13M5.85%$22.72M
Blackrock funding, inc. /de3.27M5.12%$12.64M
Vanguard group2.19M3.44%$8.49M
Opaleye management1.91M2.99%$4.12M
State street916.20K1.71%$6.64M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue owl capital lp4.65M4.15%$18.01M
Opaleye management1.91M0.92%$4.12M
Deerfield management company, l.p. (series c)21.23M0.90%$45.65M
Altium capital management lp505.00K0.55%$1.95M
Mangrove partners770.23K0.33%$2.98M
Sphera funds management455.60K0.32%$1.76M
Dafna capital management371.43K0.23%$798.58K
Ra capital management6.05M0.22%$13.00M
Velan capital investment management lp28.00K0.06%$60.20K
Ubs oconnor188.54K0.06%$729.66K

Top Buyers

HolderShares% AssetsChange
Opaleye management1.91M0.92%1.91M
Janus henderson group6.44M0.01%876.43K
Blackrock3.13M0.00%795.19K
Blue owl capital lp4.65M4.15%486.21K
Millennium management673.01K0.00%418.06K

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp---2.10M
Driehaus capital management356.00K0.01%-913.86K
Fred alger management---737.55K
Stempoint capital lp---704.35K
Logos global management lp---700.00K

New Positions

HolderShares% AssetsChangeValue
Opaleye management1.91M0.92%1.91M$4.12M
Alps advisors51.59K0.00%51.59K$199.65K
Walleye trading25.00K0.00%25.00K$96.75K
Proshare advisors14.87K0.00%14.87K$57.55K
China universal asset management13.53K0.00%13.53K$52.36K

Sold Out

HolderChange
National bank of canada /fi/-2.00
Federated hermes-3.00
Ifp advisors-4.00
Nelson, van denburg & campbell wealth management group-5.00
Signaturefd-8.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202510-91.80%31,178,885-50.84%480.49%5-92.19%1-97.14%
Dec 31, 2024116-8.66%61,296,513-4.71%960.95%61-6.15%32-5.88%
Sep 30, 202412715.45%64,329,114-1.50%1000.68%654.84%34-
Jun 30, 2024110-1.79%65,308,4722.69%1210.58%62-17.33%3454.55%
Mar 31, 202411251.35%63,594,67361.18%1441.79%75150.00%22-15.38%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.34M2.10%-
Vanguard Total Stock Mkt Idx Inv1.31M2.04%-
iShares Russell 2000 ETF1.08M1.68%528.00
Fidelity Advisor Biotechnology I524.80K0.82%-
Vanguard Institutional Extnd Mkt Idx Tr510.24K0.80%-
Invesco Dorsey Wright SmallCap Momt ETF422.53K0.66%-
Fidelity Small Cap Index422.46K0.66%-
Alger Small Cap Growth B398.96K0.62%-
iShares Russell 2000 Growth ETF390.40K0.61%-
Heptagon Driehaus US Micro Cap Eq C$ Acc387.15K0.61%-2.69K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 16, 2024Hamilton Thomas Edward-Buy$500.00K
Feb 16, 2024Flynn James E * Director by DeputizationBuy$12.50M
Feb 16, 2024Flynn James E * Director by DeputizationBuy$12.50M
Feb 16, 2024Flynn James E * Director by DeputizationBuy$12.50M
Feb 14, 2024THOMAS FRANK E-Buy$22.00K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q2--
2024 Q15-
2023 Q41-

LRMR Ownership FAQ


Who Owns Larimar Therapeutics?

Larimar Therapeutics shareholders are primarily institutional investors at 48.74%, followed by 1.43% insiders and 49.83% retail investors. The average institutional ownership in Larimar Therapeutics's industry, Biotech Stocks , is 63.96%, which Larimar Therapeutics falls below.

Who owns the most shares of Larimar Therapeutics?

Larimar Therapeutics’s largest shareholders are Deerfield management company, l.p. (series c) (21.23M shares, 33.19%), Janus henderson group (6.44M shares, 10.10%), and Ra capital management (6.05M shares, 9.45%). Together, they hold 52.74% of Larimar Therapeutics’s total shares outstanding.

Does Blackrock own Larimar Therapeutics?

Yes, BlackRock owns 5.85% of Larimar Therapeutics, totaling 3.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 795.19K shares, a 34.00% change.

Who is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.15% of its assets in 4.65M Larimar Therapeutics shares, valued at 18.01M$.

Who is the top mutual fund holder of Larimar Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Larimar Therapeutics shares, with 2.10% of its total shares outstanding invested in 1.34M Larimar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools